Like to hear how leaders are positioning this. Is it just about data science as it exists today, or is it more about data science as it supports process? The latter I would think.
Reimagining Novartis as a 'medicines and data science' company By Vas Narasimhan
Global Head of Drug Development and Chief Medical Officer at Novartis
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment